Ligand validation:4R0A

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4R0A designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4R0A_NAG_A_917	95%	19%	0.059	0.96	1.39	2.05	2	4	1	0	100%	0.9333
4R0A_NAG_A_913	50%	30%	0.117	0.866	0.72	2.03	-	7	1	0	100%	0.9333
4R0A_NAG_A_902	43%	59%	0.113	0.835	0.57	0.99	-	1	0	0	100%	0.9333
4R0A_NAG_A_905	41%	21%	0.123	0.838	0.69	2.57	-	4	2	0	100%	0.9333
4R0A_NAG_A_918	37%	29%	0.129	0.825	0.99	1.81	1	3	0	0	100%	0.9333
4R0A_NAG_A_904	36%	38%	0.134	0.824	1	1.43	1	2	0	0	100%	0.9333
4R0A_NAG_A_903	33%	54%	0.13	0.807	0.66	1.11	-	1	0	0	100%	0.9333
3WN4_NAG_A_902	95%	40%	0.057	0.96	0.85	1.46	-	3	1	0	100%	0.9333
5WYX_NAG_A_914	94%	35%	0.059	0.957	0.85	1.7	-	3	0	0	100%	0.9333
4QC0_NAG_A_905	93%	53%	0.058	0.954	0.52	1.27	-	2	0	0	100%	0.9333
5AZ5_NAG_A_913	93%	42%	0.064	0.957	0.73	1.51	-	3	2	0	100%	0.9333
3W3L_NAG_A_1016	87%	54%	0.065	0.937	0.56	1.19	-	2	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.